These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 31919525)

  • 21. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
    Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
    Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Vaccination with 10-Valent Pneumococcal Non-Typeable Haemophilus influenza Protein D Conjugate Vaccine (PHiD-CV) on the Nasopharyngeal Microbiome of Kenyan Toddlers.
    Feazel LM; Santorico SA; Robertson CE; Bashraheil M; Scott JA; Frank DN; Hammitt LL
    PLoS One; 2015; 10(6):e0128064. PubMed ID: 26083474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nasopharyngeal pneumococcal carriage in healthy Turkish children after 13-valent conjugated pneumococcal vaccine implementation in the national immunization program.
    Kanık Yüksek S; Tezer H; Gülhan B; Özkaya Parlakay A; Güldemir D; Coskun-Ari FF; Bedir Demirdağ T; Kara Uzun A; Kızılgün M; Solmaz S; Kılıç S; Yalınay Çırak M; Baran Aksakal FN
    J Infect Public Health; 2020 Feb; 13(2):266-274. PubMed ID: 31818710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pneumococcal carriage among children aged 4 - 12 years in Angola 4 years after the introduction of a pneumococcal conjugate vaccine.
    Uddén F; Filipe M; Slotved HC; Yamba-Yamba L; Fuursted K; Pintar Kuatoko P; Larsson M; Bjurgert J; Månsson V; Pelkonen T; Reimer Å; Riesbeck K
    Vaccine; 2020 Nov; 38(50):7928-7937. PubMed ID: 33143954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in pneumococcal nasopharyngeal colonization among children with respiratory tract infections before and after use of the two new extended-valency pneumococcal conjugated vaccines.
    Ahn JG; Choi SY; Kim DS; Kim KH
    Infect Dis (Lond); 2015 Jun; 47(6):385-92. PubMed ID: 25712791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic resistance of Streptococcus pneumoniae, isolated from nasopharynx of preschool children with acute respiratory tract infection in Lithuania.
    Stacevičienė I; Petraitienė S; Vaičiūnienė D; Alasevičius T; Kirslienė J; Usonis V
    BMC Infect Dis; 2016 May; 16():216. PubMed ID: 27206423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stunting correlates with high salivary and serum antibody levels after 13-valent pneumococcal conjugate vaccination of Venezuelan Amerindian children.
    Verhagen LM; Hermsen M; Rivera-Olivero I; Sisco MC; Pinelli E; Hermans PW; Berbers GA; de Waard JH; de Jonge MI
    Vaccine; 2016 Apr; 34(20):2312-20. PubMed ID: 27036512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nasopharyngeal Pneumococcal Density and Evolution of Acute Respiratory Illnesses in Young Children, Peru, 2009-2011.
    Fan RR; Howard LM; Griffin MR; Edwards KM; Zhu Y; Williams JV; Vidal JE; Klugman KP; Gil AI; Lanata CF; Grijalva CG
    Emerg Infect Dis; 2016 Nov; 22(11):1996-1999. PubMed ID: 27767919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial.
    Dagan R; Patterson S; Juergens C; Greenberg D; Givon-Lavi N; Porat N; Gurtman A; Gruber WC; Scott DA
    Clin Infect Dis; 2013 Oct; 57(7):952-62. PubMed ID: 23804191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of the Nasopharyngeal Microbiota in Infants with Cystic Fibrosis.
    Prevaes SM; de Winter-de Groot KM; Janssens HM; de Steenhuijsen Piters WA; Tramper-Stranders GA; Wyllie AL; Hasrat R; Tiddens HA; van Westreenen M; van der Ent CK; Sanders EA; Bogaert D
    Am J Respir Crit Care Med; 2016 Mar; 193(5):504-15. PubMed ID: 26492486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media.
    Cohen R; Levy C; Bingen E; Koskas M; Nave I; Varon E
    Pediatr Infect Dis J; 2012 Mar; 31(3):297-301. PubMed ID: 22330166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacterial and viral respiratory tract microbiota and host characteristics in children with lower respiratory tract infections: a matched case-control study.
    Man WH; van Houten MA; Mérelle ME; Vlieger AM; Chu MLJN; Jansen NJG; Sanders EAM; Bogaert D
    Lancet Respir Med; 2019 May; 7(5):417-426. PubMed ID: 30885620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors associated with pneumococcal carriage and density in infants and young children in Laos PDR.
    Dunne EM; Choummanivong M; Neal EFG; Stanhope K; Nguyen CD; Xeuatvongsa A; Satzke C; Sychareun V; Russell FM
    PLoS One; 2019; 14(10):e0224392. PubMed ID: 31661527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal association of infant immunisation with pneumococcal conjugate vaccine on the ecology of Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus nasopharyngeal colonisation in a rural South African community.
    Nzenze SA; Shiri T; Nunes MC; Klugman KP; Kahn K; Twine R; de Gouveia L; von Gottberg A; Madhi SA
    Vaccine; 2014 Sep; 32(42):5520-30. PubMed ID: 25101982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early respiratory microbiota composition determines bacterial succession patterns and respiratory health in children.
    Biesbroek G; Tsivtsivadze E; Sanders EA; Montijn R; Veenhoven RH; Keijser BJ; Bogaert D
    Am J Respir Crit Care Med; 2014 Dec; 190(11):1283-92. PubMed ID: 25329446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The microbiota in respiratory tract infections: from association to intervention.
    Koenen MH; de Steenhuijsen Piters WAA; Bogaert D; Verhagen LM
    Curr Opin Infect Dis; 2022 Jun; 35(3):215-222. PubMed ID: 35665715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of thirteen-valent pneumococcal conjugate vaccine on nasopharyngeal carriage in healthy children under 24 months in Okinawa, Japan.
    Chang B; Akeda H; Nakamura Y; Hamabata H; Ameku K; Toma T; Miyagi M; Ohnishi M
    J Infect Chemother; 2020 May; 26(5):465-470. PubMed ID: 31926843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carriage of Haemophilus influenzae is associated with pneumococcal vaccination in Italian children.
    Camilli R; Vescio MF; Giufrè M; Daprai L; Garlaschi ML; Cerquetti M; Pantosti A
    Vaccine; 2015 Aug; 33(36):4559-64. PubMed ID: 26190092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity of a 7-valent pneumococcal conjugate vaccine (PCV7) and impact on carriage in Venezuelan children at risk of invasive pneumococcal diseases.
    Rivera-Olivero IA; Del Nogal B; Fuentes M; Cortez R; Bogaert D; Hermans PW; Waard JH
    Vaccine; 2014 Jun; 32(31):4006-11. PubMed ID: 24837505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis among healthy children attending a day-care centre before and after official financial support for the 7-valent pneumococcal conjugate vaccine and H. influenzae type b vaccine in Japan.
    Oikawa J; Ishiwada N; Takahashi Y; Hishiki H; Nagasawa K; Takahashi S; Watanabe M; Chang B; Kohno Y
    J Infect Chemother; 2014 Feb; 20(2):146-9. PubMed ID: 24582389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.